A case series studying patients with FCCH in tuberous sclerosis patients identified heterozygous pathogenic variants in the TSC2 gene in tumor tissue samples, without evidence of a TSC2 second hit, suggesting a potential genotype-phenotype correlation [2]. Here, TSC2 is linked to neoplasm.